Product Name: EDG3 antibody
Applications: ICC/IF, IHC-P
Predicted Target Size:
Positive Controls:
Form Supplied: Liquid
Concentration: 1 mg/ml (Please refer to the vial label for the specific concentration)
Purification: Peptide immunogen affinity column
Full Name: sphingosine-1-phosphate receptor 3
Background: EDG3, a Lysophospholipid/Lysosphingolipid Receptor, binds the vasoconstrictor sphingosine-1-phosphate and activates transcription of serum response element-driven reporter genes. EDG3 may regulate angiogenesis and vascular endothelial cell functions. EDG3 has been reported in all tissues, with highest levels in heart, placenta, kidney, and liver. ESTs have been isolated from placenta and germ cell tumor libraries.
Synonyms: 601965, FLJ37523, EDG-3, Q99500, MGC71696, S1P3, LPB3, 1903, S1PR3, EDG3, EDG 3
Cellular Localization:
CAS NO: 38194-50-2
Product: Naltrexone (Hydrochloride)
Host: Rabbit
Clonality: Polyclonal
Isotype: IgG
Immunogen: Synthetic peptide – KLH conjugated. Peptide sequence identity/similarity to Mouse: 72/94%. Rat: 0/0%.
Antigen Species: Mouse
Species Reactivity: Human
Conjugation: Unconjugated
Storage Buffer: Phosphate buffered saline, pH 7.4, containing 0.01% sodium azide
Storage Instruction: Keep as concentrated solution. Store at 4ºC short term. For extended storage aliquot and store at -20ºC or below. Avoid freeze-thaw cycles.
Notes: For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Specificity:
PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/24880666?dopt=Abstract
